2026. Bimekizumab Remission and High Disease Control Over 4 years in Patients with Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s758. DOI:https://doi.org/10.25251/0bnq3318.